Stem (STEM) Cash & Equivalents (2020 - 2026)

Stem's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $36.6 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 37.55% year-over-year to $36.6 million; the TTM figure through Mar 2026 stood at $36.6 million (down 37.55% YoY), while the FY2025 annual figure was $48.9 million, down 13.12% from the prior year.
• Cash & Equivalents was $36.6 million for Q1 2026 at Stem, down from $48.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $174.5 million in Q1 2022 to a low of $36.6 million in Q1 2026.
• Historically, Cash & Equivalents has averaged $86.6 million across 5 years, with a median of $87.9 million in 2022.
• Biggest YoY gain for Cash & Equivalents was 40856.29% in 2022; the steepest drop was 88.24% in 2022.
• A 5-year view of Cash & Equivalents shows it stood at $87.9 million in 2022, then increased by 19.88% to $105.4 million in 2023, then sank by 46.57% to $56.3 million in 2024, then slipped by 13.12% to $48.9 million in 2025, then slipped by 25.2% to $36.6 million in 2026.
• The last three Cash & Equivalents figures came in at $36.6 million (Q1 2026), $48.9 million (Q4 2025), and $43.1 million (Q3 2025), per Business Quant data.